Back to Search
Start Over
1812TiP IDeate-Lung03: A Phase Ib/II study of ifinatamab deruxtecan (I-DXd) plus atezolizumab (atezo) with or without carboplatin (carbo) as first-line (1L) induction or maintenance in patients (pts) with extensive stage (ES) small cell lung cancer (SCLC)
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS1074-S1074. 1p. - Publication Year :
- 2024
- Subjects :
- *SMALL cell lung cancer
*CARBOPLATIN
*ATEZOLIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179693250
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.1903